Aycan Asik
Mugla, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Correction: The impact of inhibiting the Hippo signaling pathway effector molecule YAP1 on in vitro glioblastoma and glioblastoma stem cells.
Journal: Scientific reports
Published: April 21, 2026
Temozolomide and ruxolitinib combination modulates miRNA-associated regulatory networks in glioblastoma stem cells.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: April 09, 2026
Defeating miR-181a-3p may potentiate the effect of paclitaxel on G2/M arrest in breast cancer stem cells.
Journal: Medical oncology (Northwood, London, England)
Published: June 27, 2025
The impact of inhibiting the Hippo signaling pathway effector molecule YAP1 on in vitro glioblastoma and glioblastoma stem cells.
Journal: Scientific reports
Published: June 25, 2025
Cancer stemness kinase inhibitor amcasertib: a promising therapeutic agent in ovarian cancer stem and cancer cell models with different genetic profiles.
Journal: Medical oncology (Northwood, London, England)
Published: September 04, 2023
The effects of PKI-402 on breast tumor models' radiosensitivity via dual inhibition of PI3K/mTOR.
Journal: International journal of radiation biology
Published: June 30, 2023
The effect of the ATM inhibitor AZD0156 on the radiosensitivity of human breast cancer and lung fibroblast cells.
Journal: Journal of cancer research and therapeutics
Published: April 03, 2023
Comparative expression analysis of dasatinib and ponatinib-regulated lncRNAs in chronic myeloid leukemia and their network analysis.
Journal: Medical oncology (Northwood, London, England)
Published: November 09, 2021
PI3K/mTOR dual-inhibition with VS-5584 enhances anti-leukemic efficacy of ponatinib in blasts and Ph-negative LSCs of chronic myeloid leukemia.
Journal: European journal of pharmacology
Published: June 17, 2021
Temozolomide treatment combined with AZD3463 shows synergistic effect in glioblastoma cells.
Journal: Biochemical and biophysical research communications
Published: October 08, 2020
Combination of Salinomycin and AZD3463 Reveals Synergistic Effect on Reducing the Viability of T98G Glioblastoma Cells.
Journal: Anti-cancer agents in medicinal chemistry
Published: April 18, 2020
The Evaluation of Effect of Aurora Kinase Inhibitor CCT137690 in Melanoma and Melanoma Cancer Stem Cell.
Journal: Anti-cancer agents in medicinal chemistry
Published: March 28, 2020
Last Updated: 09/26/2026